Key Takeaway: PTC Therapeutics, Inc. announced its participation in several upcoming investor conferences, including the TD Cowen 46th Annual Health Care Conference and the Barclays Global Healthcare Conference. Executives will present on March 2, March 10, and March 11, with live webcasts available for investors. The company emphasizes its mission to develop treatments for rare disorders.
Price reaction · baseline $70.66 (2026-02-20 close) · hit pre-market · clean, no other PTCT news in the window
day 0 close
-0.2%
Market Sentiment Analysis
POSITIVE FACTORS
PTC Therapeutics is actively engaging with investors through multiple conferences.
The company showcases its commitment to transparency by webcasting presentations.
PTC is dedicated to addressing unmet medical needs with its innovative pipeline.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis
Full Press Release Details
WARREN, N.J.,Feb. 23, 2026/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) today announced that its executives will speak at the following conferences:
TD Cowen 46th Annual Health Care Conference 2026
Monday, March 2 at 9:50 a.m. ET
Leerink 2026 Global Healthcare ConferenceTuesday, March 10 at 4:20 p.m. ET
Barclays Global Healthcare Conference 2026Wednesday, March 11 at 8 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website athttps://ir.ptcbio.com/events-presentationsand will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes before the start of the webcast to ensure a timely connection.
ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visitwww.ptcbio.comand follow us on LinkedIn, X, Instagram and Facebook.
Investors:
Frequently Asked Questions
When will PTC Therapeutics present at the conferences?
PTC Therapeutics will present on March 2, March 10, and March 11, 2026.
How can I watch the presentations?
The presentations will be webcast live on PTC's website and archived for 30 days.
What is the focus of PTC Therapeutics?
PTC is focused on developing medicines for children and adults with rare disorders.
Where can I find more information about PTC?
More information is available on PTC's official website and social media platforms.